Combination Inhalers
- Long acting beta-agonists (LABA) are the preferred first option for add-on therapy, usually beyond an ICS dose of 400mcg Beclometasone equivalent per day in adults and 200mcg per day in children.
- In accordance with NICE guidance, the use of a combination inhaler is recommended as an option for patients in whom an inhaled steroid and a LABA are considered appropriate.
- Combination inhalers have the advantage, once a patient is on stable therapy, of guaranteeing that the LABA is not taken without the inhaled steroid
Back to Management of asthma in adults